U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Center for Devices and Radiological Health : Center for Food Safety and Applied Nutrition,
Guidance for industry [electronic resource] : postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic.
Postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic
United States. Food and Drug Administration. Office of Counterterrorism and Emerging Threats.
Center for Drug Evaluation and Research (U.S.)
Center for Biologics Evaluation and Research (U.S.)
Center for Devices and Radiological Health (U.S.)
Center for Food Safety and Applied Nutrition (U.S.)
Guidance for industry [electronic resource] : postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic.